Bicycle Therapeutics Plc (BCYC) SEC Filing 8-K Material Event for the period ending Thursday, September 26, 2019

Bicycle Therapeutics Plc

CIK: 1761612 Ticker: BCYC

View differences made from one to another to evaluate Bicycle Therapeutics Plc's financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 8-K Corporate News to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Bicycle Therapeutics Plc.


Assess how Bicycle Therapeutics Plc's management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Bicycle Therapeutics Plc's Definitive Proxy Statement (Form DEF 14A) filed after their 2019 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors



Material Contracts, Statements, Certifications & more

Bicycle Therapeutics Plc provided additional information to their SEC Filing as exhibits

Ticker: BCYC
CIK: 1761612
Form Type: 8-K Corporate News
Accession Number: 0001104659-19-052038
Submitted to the SEC: Mon Sep 30 2019 4:04:58 PM EST
Accepted by the SEC: Mon Sep 30 2019
Period: Thursday, September 26, 2019
Industry: Pharmaceutical Preparations
  1. Event for Officers
  2. Financial Exhibit

External Resources:
Stock Quote
Social Media

Bookmark the Permalink: